Table 1 Baseline characteristics

Parameter

Mean (SD)

Median

Range

 Age (years)

48 (12)

47

28–67

 Weight (kg)

65 (9)

66

50–79

 Height (cm)

169 (8)

170

157–184

 Sex

  Female (n)

7

–

–

  Male (n)

2

–

–

 Disease duration (months) since

  Onset of Raynaud’s phenomenon

32 (38)

17

2–120

  Onset of skin involvement

20 (16)

16

8–58

 mRSS

28 (10)

25

19–46

 QoL^a

  HAQ-DI

1.1 (0.6)

1.0

0.5–2.2

  SF-36 Physical component sum

35 (12)

37

17–48

Parameter

Yes

No

Unknown

 Antinuclear antibody (ANA) positive (n)

9

0

0

 Anti-RNA polymerase III positive (n)

3

5

1

 Anti-topoisomerase I positive (n)

5

3

1

 Lung fibrosis (by high-resolution CT) (n)

3

6

0

 Pitting scars (n)

4

5

0

 Digital ulcers (n)

1

8

0

 Ongoing corticosteroid treatment^b (n)

3

6

0

 Previous immunosuppressive treatment (n)

0

9

0